Depression is a condition associated with chemical imbalances in the brain. Such a state of mind leads to hopelessness, anxiousness, panic, insomnia. It has been recently approved that Selegiline patch is the very first transdermal treatment for the cure of depression. A concentration of as low as 20 mg is the first ever MAQ inhibitor proven for its relieving and muscle soothing effects without the requirement for any dietary changes in particular.
It is important to note that the oral formulation of this patch has been popularly used for the treatment of Parkinson’s disease. However, this oral formulation fails to show effects of anti-depressants at the central nervous system. Furthermore, studies have revealed that the concentrations of 20 mg, 30 mg and 40 mg may take a time frame of 6, 8, 52 weeks for the absolute cure of depression. Concentration of the same more than 40 mg is under production by its company and has not been released into the market yet.
The patients put on anti-depressant dosages were given certain instruction on dietary abstinence particularly from food sources containing tyramine. However, those experimenting with this patch are not given any such restrictions and are nearly free to choose from a variety of food for consumption. |
Lithium Antidepressant Information
